Patient Care FDA Approves Destination Therapy Device for Heart Failure Apr. 8, 2010 Facebook Twitter LinkedIn Email Skip breadcrumb URMC Home Newsroom News FDA Approves Destination Therapy Device for Heart Failure URMC only site in upstate N.Y. to offer HeartMate II LVAD
